Medtech company Carthera, a spin-off from Sorbonne University, announced an additional €4.5 million in funding to complement its Series B financing round, bringing the total raised to €42 million.
Carthera is a clinical-stage medtech company focused on developing innovative ultrasound-based medical devices to treat various brain disorders.
It leverages the inventions of Professor Alexandre Carpentier, head neurosurgeon at AP-HP Sorbonne University, who has achieved worldwide recognition for his innovative developments in treating brain disorders.